FTO Full Analysis

SKU: PT-08

A more thorough FTO before commercial launch, fundraising diligence, or licensing discussions.

$6,500.00

Quantity

Buy Now

Engagement type: Flat Fee

Attorney fee: $6,500
$6,500 (flat)
USPTO / USCO / WIPO fees billed separately at cost.

Best for
A more thorough FTO before commercial launch, fundraising diligence, or licensing discussions.

What’s included

Expanded patent search across U.S. patents and published applications.
Attorney review and prioritization of higher-risk references.
Written opinion with claim-by-claim risk commentary on the most relevant references.

What’s NOT included

Government, third-party, foreign-associate, translation, courier, and vendor fees.
Continued prosecution, additional office actions, or post-allowance work beyond what is expressly itemized.
Litigation, contested proceedings (IPR/PGR/PTAB, oppositions, cancellations), or appeal work.
Work on additional applications, jurisdictions, classes, or marks not listed in the engagement letter.
Worldwide FTO (separate quote).

Client responsibilities

Assumptions

Standard complexity for the service category.
One primary applicant or business entity; one primary jurisdiction unless otherwise stated.
One round of substantive client revisions included.
No material adverse facts (e.g., prior public disclosure, intervening prior art) discovered after engagement.
U.S. jurisdiction; single product line; single technical field.

Scope-change triggers

Material change in scope, claims, embodiments, classes, marks, or jurisdictions.
Adversarial action by a third party (opposition, cancellation, declaratory action).
Expedited / emergency turnaround required to meet a statutory or self-imposed deadline.
After-discovered prior art, prior use, or undisclosed prior filings.

Deliverables
Written FTO opinion (typically 12–20 pages).

Typical timing
Typically 4–6 weeks.

A streamlined provisional offering listed on the firm's website at a promotional rate.

Sophisticated inventors who will supply a substantially complete written disclosure and want attorney review and filing.

Reviewing the IP position around a specific biomarker, panel, or signature before clinical, commercial, or licensing decisions.

Patentability work in molecular biology, diagnostics, therapeutics, and related life-science areas, where literature volume drives effort.

Decisions about whether and how to file continuations, continuation-in-part, or divisional applications to extend or refine claim coverage.

Streamlined design patent filings for single-design products.

You filed. That does not mean you are covered.